A pharmaceutical study on in-situ gelling mucoadhesive formulations for rectal administration /
Kholoud Mamdouh Abdelfattah Mohamed
A pharmaceutical study on in-situ gelling mucoadhesive formulations for rectal administration / دراسة صيدلية علي تركيبات دوائية في صورة محلول هلامي موضعي ملاصق للمخاط بالمستقيم Kholoud Mamdouh Abdelfattah Mohamed ; Supervised Dalia Mahmoud Ghorab , Marwa H. Shukr - Cairo : Kholoud Mamdouh Abdelfattah Mohamed , 2019 - 186 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Chronic anal fissures (CAF) is a troubling and painful condition that affects a great majority of population. Its current clinical management options are either operative or non-operative treatment. Innovative prospects for non-operative medical treatment have been lately employed taking in consideration reduction of the internal anal sphincter (IAS) muscle tone. Phosphodiesterase inhibitors (PDEIs) have proven to cause a dose-dependent reduction in the tone of the internal anal sphincter muscle and promote wound healing. Dipyridamole (DP) as phosphodiesterase inhibitor was selected for topical rectal application in the treatment of anal fissures. As DP is a poorly soluble drug, enhancing its solubility represented a rate limiting step for its formulation.Therefore, microemulsion (ME) technique was used to provide a proper enhancement for DP solubilization. Dipyridamole ME formulations were loaded on to thermosensitive in-situ gel dosage form to facilitate rectal administration. Poloxamer 407 (P 407) was used as the thermosensitive polymer as it exhibits sol-gel transition at body temperature (37C).The prepared in-situ gel formulations were provided with mucoadhesive polymers as Sodium alginate (Na Alg.) and Hydroxypropyl methyl cellulose (HPMC) to prolong the residence time of the prepared formulation at the site of action
Chronic anal fissures (CAF) In-situ gelling mucoadhesive Rectal administration
A pharmaceutical study on in-situ gelling mucoadhesive formulations for rectal administration / دراسة صيدلية علي تركيبات دوائية في صورة محلول هلامي موضعي ملاصق للمخاط بالمستقيم Kholoud Mamdouh Abdelfattah Mohamed ; Supervised Dalia Mahmoud Ghorab , Marwa H. Shukr - Cairo : Kholoud Mamdouh Abdelfattah Mohamed , 2019 - 186 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
Chronic anal fissures (CAF) is a troubling and painful condition that affects a great majority of population. Its current clinical management options are either operative or non-operative treatment. Innovative prospects for non-operative medical treatment have been lately employed taking in consideration reduction of the internal anal sphincter (IAS) muscle tone. Phosphodiesterase inhibitors (PDEIs) have proven to cause a dose-dependent reduction in the tone of the internal anal sphincter muscle and promote wound healing. Dipyridamole (DP) as phosphodiesterase inhibitor was selected for topical rectal application in the treatment of anal fissures. As DP is a poorly soluble drug, enhancing its solubility represented a rate limiting step for its formulation.Therefore, microemulsion (ME) technique was used to provide a proper enhancement for DP solubilization. Dipyridamole ME formulations were loaded on to thermosensitive in-situ gel dosage form to facilitate rectal administration. Poloxamer 407 (P 407) was used as the thermosensitive polymer as it exhibits sol-gel transition at body temperature (37C).The prepared in-situ gel formulations were provided with mucoadhesive polymers as Sodium alginate (Na Alg.) and Hydroxypropyl methyl cellulose (HPMC) to prolong the residence time of the prepared formulation at the site of action
Chronic anal fissures (CAF) In-situ gelling mucoadhesive Rectal administration